Interv Akut Kardiol. 2012;11(2):76-77

Is implantable cardioverter-defibrillators testing necessary?

Jan Lukl
I. interní klinika &ndash, kardiologická, LF UP a FN Olomouc

This review contains in the first part the discussion about the various type of implantable-defibrillators testing, their advantages and

disadvantages. In the second part the question is discussed, whether is the testing necessary. The advantage and disadvantages of testing

are discussed. Author concludes that because there are no randomized studies, the question cannot be answered. Untill the results

of randomized studies are available, author recommends limited testing, e.g. single test for defibrillation safety margin.

Keywords: implantable cardioverter-defibrillator testing, defibrillator safety margin test, upper limit of vulnerability

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lukl J. Is implantable cardioverter-defibrillators testing necessary? Interv Akut Kardiol. 2012;11(2):76-77.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gregoratos G, Abrams J, Epstein AE. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmic device - summary article. J Am Coll Cardiol 2002; 40: 1702-1719. Go to original source... Go to PubMed...
    2. Dworschak M, Franz M, Czerny M, et al. Release of neuronspecific enolase and S100 after implantation of cardioverters/ defibrillators. Crit Care Med 2003; 31: 2085-2089. Go to original source... Go to PubMed...
    3. Weigl M, Moritz A, Steinlechner B, et al. Neuronal injury after repeated brief cardiac arrests during internal cardioverter defibrillator implantation is associated with deterioration of cognitive function. Anesth Analg 2006; 103: 403-409. Go to original source... Go to PubMed...
    4. Singer I, Lang D. Defibrillation threshold: Clinical utility and therapeutic implication. Pacing Clin Electrophysiol 1992; 15: 932-940. Go to original source... Go to PubMed...
    5. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007; 30: 675-700. Go to original source... Go to PubMed...
    6. Brignole M, Raciti G, Bongiorni MG, et al. Defibrillation testing at the time of implantation of cardioverter- defibrillator in the clinical practice: a nation-wide survey. Europace 2007; 9: 540-543. Go to original source... Go to PubMed...
    7. Pacifico A, Cedillo-Salazar FR, Nasir N Jr, Doyle TK, Henry PD. Conscious sedation with combined hypnotic agents for implantation of implantable cardioverter-defibrillators. J Am Coll Cardiol 1997; 30: 769-773. Go to original source... Go to PubMed...
    8. Morgan JM, Marinskis G. Defibrillation testing at the time of implantable cardioverter defibrillator implantation: result of the European Hert Rhythm Assoiciation survay. Europace 2011; 13: 581-582. Go to original source... Go to PubMed...
    9. Hui RC, Rosenthal L, Ramza B, et al. Relationship beween the upper limit of vulnerability determined in normal sinus rhythm and the defibrillation threshold in patiens with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1998; 21: 687-693. Go to original source... Go to PubMed...
    10. Swerdlow CD, Shehata M, Chen PS. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs. Pacing Clin Electrophysiol 2007; 30: 253-270. Go to original source... Go to PubMed...
    11. Healey JS, Dorian P, Mitchell LB, et al. Canadian registry of ICD implant testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing. J Cardiovasc Elecctrophysiol 2010; 21: 177-182. Go to original source... Go to PubMed...
    12. Sauer VH, Lowery CM, Bargas RL, et al. Utility of postoperative testing of implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2011; 34: 186-192. Go to original source... Go to PubMed...
    13. Luis A, Pires LA, Johnson KM. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? J Cardiovasc Electrophysiol 2006; 17: 140-145. Go to original source... Go to PubMed...
    14. Stefano B, Pietro RR, Maurizio G, et al. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assesment of Long-term Induction clinical ValuE (ALIVE) project. Am Heart J 2011; 162: 390-397. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.